about
Potential mechanisms of progranulin-deficient FTLDPGC-1α, mitochondrial dysfunction, and Huntington's diseaseGenetics and neuropathology of Huntington's diseaseLocalization of CAM II kinase-alpha, GAD, GluR2 and GABA(A) receptor subunit mRNAs in the human entorhinal cortexShaping the role of mitochondria in the pathogenesis of Huntington's diseaseHuntington disease models and human neuropathology: similarities and differencesHuntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem.Monitoring Huntington's disease progression through preclinical and early stagesAltered diffusion tensor imaging measurements in aged transgenic Huntington disease ratsCerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneityOxidative Stress and Huntington's Disease: The Good, The Bad, and The Ugly.Antioxidants in Huntington's disease.A mitochondrial basis for Huntington's disease: therapeutic prospects.Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain.Polyglutamine aggregation in Huntington's disease and spinocerebellar ataxia type 3: similar mechanisms in aggregate formation.Huntington's Disease (HD): Neurodegeneration of Brodmann's Primary Visual Area 17 (BA17).Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease.Disrupted striatal neuron inputs and outputs in Huntington's disease.
P2860
Q26863702-9E6DF606-C63A-4995-9364-4C688095A40CQ27001671-EED8DB03-A76C-42ED-819C-95DFCD19596FQ27023050-611775DD-03ED-4E0D-9875-A5E0B5FAF312Q28238432-3B81A3BB-AFA4-4D2A-B702-7100F6C6853EQ28384036-D8A70F2C-34E2-4EBD-A696-79C0EBA2D02DQ33760994-EC38A856-2445-4E02-BE72-97054E59028FQ34162629-263C6707-2535-4114-8392-B20A9125D621Q36459201-3DBCEFFF-CBFA-48C8-91D3-81A0D662F08FQ36652239-07D110AF-A48A-4141-869E-49AFB1E8E4FAQ37132239-EA099628-F060-4C9F-B507-BCEF1337A02FQ37643688-239A4ADA-2EDA-4DEA-8134-FA9BE070BB1BQ37964359-BB15ADD9-BED1-4596-8DEC-6899214CCB51Q38174451-1C22BD58-FFB2-4C39-90A5-A26ABCEFF24EQ39193175-9628A325-6B29-4DFA-9448-499614C85CB4Q45288723-FC53C826-3510-4E19-8E73-D9230FF1FE2BQ45303234-A2BB70B2-AE3C-4C75-8F8A-7C901567FCC3Q45305124-60A5A00A-FDB7-4891-B1E1-E598E63AF315Q52690256-96FD3AA4-FF88-415C-9537-C05A574C1F0A
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
Allocortical involvement in Huntington's disease.
@en
Allocortical involvement in Huntington's disease.
@nl
type
label
Allocortical involvement in Huntington's disease.
@en
Allocortical involvement in Huntington's disease.
@nl
prefLabel
Allocortical involvement in Huntington's disease.
@en
Allocortical involvement in Huntington's disease.
@nl
P2860
P1476
Allocortical involvement in Huntington's disease.
@en
P2860
P304
P356
10.1111/J.1365-2990.1992.TB00824.X
P577
1992-12-01T00:00:00Z